P

Protagonist Therapeutics
D

PTGX

46.160
USD
-1.40
(-2.94%)
مغلق
حجم التداول
15,383
الربح لكل سهم
0
العائد الربحي
0
P/E
17
حجم السوق
2,719,035,644
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.10000
    (-2.04%)
    4.80000 USD
    A
    ALLO
    -0.21500
    (-7.29%)
    2.73500 USD
    B
    BLUE
    -0.06000
    (-5.26%)
    1.08000 USD
    C
    CRSP
    -2.450
    (-4.28%)
    54.840 USD
    E
    EDIT
    -0.28500
    (-5.26%)
    5.13500 USD
    N
    NTLA
    -1.100
    (-4.19%)
    25.130 USD
    R
    RGLS
    -0.09000
    (-5.06%)
    1.69000 USD
    S
    SGMO
    -0.09690
    (-12.11%)
    0.70340 USD
    V
    VYGR
    -0.59000
    (-6.37%)
    8.67000 USD
    المزيد
الأخبار
المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.